Kód HS/KN 300460 je pro přípravu na EUDR mimo oblast působnosti.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives) Indexovaný nástroj oblasti působnosti vrací pro tento kód výsledek Out of scope. No Annex I scope match was found for this indexed CN code.
Proč tato referenční stránka dává právě tuto odpověď.
- Popis kódu
- Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives)
- Základ v příloze I
- Bez přímé položky v příloze I
- Zdrojový základ
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Nadřazené, podřazené a sousední řádky.
Knihovní zobrazení slouží k referenční navigaci. Chcete-li spustit další kód jako akci, použijte kontrolu.
30farmaceutické výrobkyout3004medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)out30046000medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives)out300410medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail saleout300420medicaments containing antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic structure, or streptomycines or derivatives thereof)out300431medicaments containing insulin but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail saleout300432medicaments containing corticosteroid hormones, their derivatives or structural analogues but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail saleout300439medicaments containing hormones or steroids used as hormones but not antibiotics, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. medicaments containing insulin or corticosteroid hormones, their derivatives or structural analogues)out300440medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail saleout
Co to znamená pro přípravu.
Tento řádek není v aktuálním výsledku oblasti působnosti přímým spouštěčem shromažďování dokladů.
Regulation (EU) 2023/1115 Annex I — relevant productsstaženo 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115staženo 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)staženo 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)staženo 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8staženo 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingstaženo 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersstaženo 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)staženo 2026-08-08